Andersons pediatric cardiology 1900

Norwoodoperationinamulti-centreregistry:a
reportfromthenationalpediatriccardiologyqualityimprovementcollaborative.Cardiol
Young.2014;24(2):253–262.
23.PolimenakosAC,SathanandamSK,HusayniTS,
etal.Hypoplasticleftheartsyndromeandaortic
atresia-mitralstenosisvariant:roleof
myocardialprotectionstrategyandimpactof
ventriculo-coronaryconnectionsafterstageI
palliation.PediatrCardiol.2011;32(7):929–939.
24.BartramU,GrunenfelderJ,VanPraaghR.
CausesofdeathafterthemodifiedNorwood
procedure:astudyof122postmortemcases.
AnnThoracSurg.1997;64(6):1795–1802.
25.GistKM,SchuchardtEL,MorozeMK,etal.
TachyarrhythmiafollowingNorwoodoperation:
asingle-centerexperience.WorldJPediatr
CongenitHeartSurg.2014;5(2):206–210.
26.OsterME,ChenS,DagincourtN,etal.
Developmentandimpactofarrhythmiasafter
theNorwoodprocedure:areportfromthe
PediatricHeartNetwork.JThoracCardiovasc
Surg.2017;153(3):638–45e2.
27.HehirDA,DominguezTE,BallwegJA,etal.
Riskfactorsforinterstagedeathafterstage1
reconstructionofhypoplasticleftheart
syndromeandvariants.JThoracCardiovasc


Surg.2008;136(1):94–99[9e1–3].
28.HallEJ,SmithAH,FishFA,etal.Associationof
shunttypewitharrhythmiasafterNorwood

procedure.AnnThoracSurg.2018;105(2):629–
636.
29.AndersonJB,BeekmanRH3rd,EghtesadyP,et
al.Predictorsofpoorweightgainininfantswith
asingleventricle.JPediatr.2010;157(3):407–
413[13e1].
30.AndersonJB,BeekmanRH3rd,BorderWL,et
al.Lowerweight-for-agezscoreadversely
affectshospitallengthofstayafterthe
bidirectionalGlennprocedurein100infants
withasingleventricle.JThoracCardiovasc
Surg.2009;138(2):397–404e1.
31.VogtKN,ManlhiotC,VanArsdellG,etal.
Somaticgrowthinchildrenwithsingleventricle
physiologyimpactofphysiologicstate.JAm
CollCardiol.2007;50(19):1876–1883.
32.BarronDJ,HaqIU,CruceanA,etal.The
importanceofageandweightoncavopulmonary
shunt(stageII)outcomesaftertheNorwood
procedure:plannedversusunplannedsurgery.J
ThoracCardiovascSurg.2017;154(1):228–238.
33.BrownDW,MangeotC,AndersonJB,etal.
Digoxinuseisassociatedwithreduced
interstagemortalityinpatientswithnohistoryof


arrhythmiaafterstageIpalliationforsingle
ventricleheartdisease.JAmHeartAssoc.
2016;5(1).
34.OsterME,KellemanM,McCrackenC,Ohye

RG,MahleWT.Associationofdigoxinwith
interstagemortality:resultsfromthepediatric
heartnetworksingleventriclereconstruction
trialpublicusedataset.JAmHeartAssoc.
2016;5(1).
35.RamachandranP,KingE,NebbiaA,Beekman
RH,AndersonJB.Variabilityofantithrombotics
useinpatientswithhypoplasticleftheart
syndromeanditsvariantsfollowingfirst-and
second-stagepalliationsurgery:anationalreport
usingtheNationalPediatricCardiologyQuality
ImprovementCollaborativeregistry.Cardiol
Young.2017;27(4):731–738.
36.MirA,FrankS,JourneycakeJ,etal.Aspirin
ResistanceinSingle-VentriclePhysiology:
aspirinprophylaxisisnotadequatetoinhibit
plateletsintheimmediatepostoperativeperiod.
AnnThoracSurg.2015;99(6):2158–2164.
37.TruongDT,JohnsonJT,BaillyDK,etal.Platelet
inhibitioninshuntedinfantsonaspirinatshort
andmidtermFollow-Up.PediatrCardiol.
2017;38(2):401–409.
38.RomlinBS,WahlanderH,Stromvall-LarssonE,